Serum indoxyl sulfate associates with postangioplasty thrombosis of dialysis grafts

Journal of the American Society of Nephrology

Volumn 27, Issue 4, 2016, Pages 1254-1264

  Wu, Chih Cheng ^a,b,c,d   Hsieh, Mu Yang ^a,c   Hung, Szu Chun ^e,f   Kuo, Ko Lin ^e,f   Tsai, Tung Hu ^d   Lai, Chao Lun ^a,d   Chen, Jaw Wen ^d,g   Lin, Shing Jong ^d,g,h   Huang, Po Hsun ^d,g   Tarng, Der Cherng ^d,g  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAIPEI TZU CHI HOSPITAL   (Taiwan)

^f TZU CHI UNIVERSITY   (Taiwan)

^g TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^h TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INDICAN;

AGED; ARTERY THROMBOSIS; ARTICLE; COHORT ANALYSIS; CORONARY ARTERY THROMBOSIS; DEEP VEIN THROMBOSIS; DIALYSIS; FEMALE; FOLLOW UP; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECURRENCE RISK; RESTENOSIS; RISK FACTOR; THROMBOSIS; VASCULAR ACCESS; ADVERSE EFFECTS; ANGIOPLASTY; ARTERIOVENOUS SHUNT; BLOOD; HEMODIALYSIS; VASCULAR PATENCY;

AGED; ANGIOPLASTY; ARTERIOVENOUS SHUNT, SURGICAL; FEMALE; HUMANS; INDICAN; MALE; PROSPECTIVE STUDIES; RENAL DIALYSIS; THROMBOSIS; VASCULAR PATENCY;

EID: 85017057829     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015010068     Document Type: Article

References (50)

1. National Kidney Foundation-Dialysis Outcomes Quality Initiative: NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 30[Suppl 3]: S150–S191, 1997
2. US Renal Data System: USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010
3. Roy-Chaudhury P, Sukhatme VP, Cheung AK: Hemodialysis vascular access dysfunction: A cellular and molecular viewpoint. J Am Soc Nephrol 17: 1112–1127, 2006
4. Schwab SJ, Oliver MJ, Suhocki P, McCann R: Hemodialysis arteriovenous access: Detection of stenosis and response to treatment by vascular access blood flow. Kidney Int 59: 358–362, 2001
5. Moist LM, Churchill DN, House AA, Millward SF, Elliott JE, Kribs SW, DeYoung WJ, Blythe L, Stitt LW, Lindsay RM: Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol 14: 2645–2653, 2003
6. Neuen BL, Gunnarsson R, Webster AC, Baer RA, Golledge J, Mantha ML: Predictors of patency after balloon angioplasty in hemodialysis fistulas: A systematic review. J Vasc Interv Radiol 25: 917–924, 2014
7. Vanholder R, Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J; European Uremic Toxin Work Group: A bench to bedside view of uremic toxins. J Am Soc Nephrol 19: 863–870, 2008
8. Dou L, Jourde-Chiche N, Faure V, Cerini C, Berland Y, Dignat-George F, Brunet P: The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost 5: 1302–1308, 2007
9. Dou L, Bertrand E, Cerini C, Faure V, Sampol J, Vanholder R, Berland Y, Brunet P: The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 65: 442–451, 2004
10. Yu M, Kim YJ, Kang DH: Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clin J Am Soc Nephrol 6: 30–39, 2011
11. Yamamoto H, Tsuruoka S, Ioka T, Ando H, Ito C, Akimoto T, Fujimura A, Asano Y, Kusano E: Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int 69: 1780–1785, 2006
12. Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G: The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: A systematic review. J Am Soc Nephrol 25: 1897–1907, 2014
13. Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y: Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 69: 1081–1087, 2006
14. Liabeuf S, Barreto DV, Barreto FC, Meert N, Glorieux G, Schepers E, Temmar M, Choukroun G, Vanholder R, Massy ZA; European Uraemic Toxin Work Group (EUTox): Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 25: 1183–1191, 2010
15. Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, Choukroun G, Vanholder R, Massy ZA; European Uremic Toxin Work Group (EUTox): Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 4: 1551–1558, 2009
16. Neuen BL, Gunnarsson R, Baer RA, Tosenovsky P, Green SJ, Golledge J, Mantha ML: Factors associated with patency following angioplasty of hemodialysis fistulae. J Vasc Interv Radiol 25: 1419–1426, 2014
17. Lilly RZ, Carlton D, Barker J, Saddekni S, Hamrick K, Oser R, Westfall AO, Allon M: Predictors of arteriovenous graft patency after radiologic intervention in hemodialysis patients. Am J Kidney Dis 37: 945–953, 2001
18. Crowther MA, Kelton JG: Congenital thrombophilic states associated with venous thrombosis: A qualitative overview and proposed classification system. Ann Intern Med 138: 128–134, 2003
19. Schwab SJ, Harrington JT, Singh A, Roher R, Shohaib SA, Perrone RD, Meyer K, Beasley D: Vascular access for hemodialysis. Kidney Int 55: 2078–2090, 1999
20. Crowther MA, Clase CM, Margetts PJ, Julian J, Lambert K, Sneath D, Nagai R, Wilson S, Ingram AJ: Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: A randomized controlled trial. J Am Soc Nephrol 13: 2331–2337, 2002
21. Kaufman JS, O’Connor TZ, Zhang JH, Cronin RE, Fiore LD, Ganz MB, Goldfarb DS, Peduzzi PN; Veterans Affairs Cooperative Study Group on Hemodialysis Access Graft Thrombosis: Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol 14: 2313–2321, 2003
22. Ocak G, Vossen CY, Rotmans JI, Lijfering WM, Rosendaal FR, Parlevliet KJ, Krediet RT, Boeschoten EW, Dekker FW, Verduijn M: Venous and arterial thrombosis in dialysis patients. Thromb Haemost 106: 1046–1052, 2011
23. Casserly LF, Dember LM: Thrombosis in end-stage renal disease. Semin Dial 16: 245–256, 2003
24. Baskin E, Duman O, Beşbaş N, Ozen S: Hypercoagulopathy in a hemodialysis patient: Are elevations in factors VII and VIII effective? Nephron 83: 180, 1999
25. Segarra A, Chacón P, Martinez-Eyarre C, Argelaguer X, Vila J, Ruiz P, Fort J, Bartolomé J, Camps J, Moliner E, Pelegrí A, Marco F, Olmos A, Piera L: Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: Biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol 12: 1255–1263, 2001
26. Małyszko J, Małyszko JS, Hryszko T, Myśliwiec M: Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy. Thromb Haemost 91: 480–486, 2004
27. Mercier E, Branger B, Vecina F, Al-Sabadani B, Berlan J, Dauzat M, Fourcade J, Gris JC: Tissue factor coagulation pathway and blood cells activation state in renal insufficiency. Hematol J 2: 18–25, 2001
28. Knoll GA, Wells PS, Young D, Perkins SL, Pilkey RM, Clinch JJ, Rodger MA: Thrombophilia and the risk for hemodialysis vascular access thrombosis. J Am Soc Nephrol 16: 1108–1114, 2005
29. Nampoory MR, Das KC, Johny KV, Al-Hilali N, Abraham M, Easow S, Saed T, Al-Muzeirei IA, Sugathan TN, Al Mousawi M: Hypercoagulability, a serious problem in patients with ESRD on maintenance hemodialysis, and its correction after kidney transplantation. Am J Kidney Dis 42: 797–805, 2003
30. O’shea SI, Lawson JH, Reddan D, Murphy M, Ortel TL: Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis. J Vasc Surg 38: 541–548, 2003
31. LeSar CJ, Merrick HW, Smith MR: Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access. J Am Coll Surg 189: 73–79, discussion 79–81, 1999
32. Gondouin B, Cerini C, Dou L, Sallée M, Duval-Sabatier A, Pletinck A, Calaf R, Lacroix R, Jourde-Chiche N, Poitevin S, Arnaud L, Vanholder R, Brunet P, Dignat-George F, Burtey S: Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway. Kidney Int 84: 733–744, 2013
33. Chitalia VC, Shivanna S, Martorell J, Balcells M, Bosch I, Kolandaivelu K, Edelman ER: Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor. Circulation 127: 365–376, 2013
34. de Groot K, Bahlmann FH, Sowa J, Koenig J, Menne J, Haller H, Fliser D: Uremia causes endothelial progenitor cell deficiency. Kidney Int 66: 641–646, 2004
35. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R: Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8: 403–409, 2002
36. Wu VC, Young GH, Huang PH, Lo SC, Wang KC, Sun CY, Liang CJ, Huang TM, Chen JH, Chang FC, Chen YL, Kuo YS, Chen JB, Chen JW, Chen YM, Ko WJ, Wu KD; NSARF group: In acute kidney injury, indoxyl sulfate impairs human endothelial progenitor cells: Modulation by statin. Angiogenesis 16: 609–624, 2013
37. Wu CC, Huang PH, Lai CL, Leu HB, Chen JW, Lin SJ: The impact of endothelial progenitor cells on restenosis after percutaneous angioplasty of hemodialysis vascular access. PLoS One 9: e101058, 2014
38. Lev EI, Leshem-Lev D, Mager A, Vaknin-Assa H, Harel N, Zimra Y, Bental T, Greenberg G, Dvir D, Solodky A, Assali A, Battler A, Kornowski R: Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis. Eur Heart J 31: 2625–2632, 2010
39. Yisireyili M, Saito S, Abudureyimu S, Adelibieke Y, Ng HY, Nishijima F, Takeshita K, Murohara T, Niwa T: Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells. PLoS One 9: e109268, 2014
40. Cheng YJ, Liu ZH, Yao FJ, Zeng WT, Zheng DD, Dong YG, Wu SH: Current and former smoking and risk for venous thromboembolism: A systematic review and meta-analysis. PLoS Med 10: e1001515, 2013
41. Barua RS, Ambrose JA: Mechanisms of coronary thrombosis in cigarette smoke exposure. Arterioscler Thromb Vasc Biol 33: 1460–1467, 2013
42. Vazzana N, Ranalli P, Cuccurullo C, Davì G: Diabetes mellitus and thrombosis. Thromb Res 129: 371–377, 2012
43. Chou CY, Kuo HL, Yung YF, Liu YL, Huang CC: C-reactive protein predicts vascular access thrombosis in hemodialysis patients. Blood Purif 24: 342–346, 2006
44. Chang CJ, Ko YS, Ko PJ, Hsu LA, Chen CF, Yang CW, Hsu TS, Pang JH: Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity. Kidney Int 68: 1312–1319, 2005
45. Miyazaki T, Ise M, Hirata M, Endo K, Ito Y, Seo H, Niwa T: Indoxyl sulfate stimulates renal synthesis of transforming growth factor-beta 1 and progression of renal failure. Kidney Int Suppl 63: S211–S214, 1997
46. Lin CJ, Wu CJ, Pan CF, Chen YC, Sun FJ, Chen HH: Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients. Nephrol Dial Transplant 25: 3693–3700, 2010
47. Wu IW, Hsu KH, Hsu HJ, Lee CC, Sun CY, Tsai CJ, Wu MS: Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients–a prospective cohort study. Nephrol Dial Transplant 27: 1169–1175, 2012
48. Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC: Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction. Am Heart J 157: 688–694, 2009
49. Vascular Access 2006 Work Group: Clinical practice guidelines for vascular access. Am J Kidney Dis 48[Suppl 1]: S176–S247, 2006
50. Wu CC, Lin MC, Pu SY, Tsai KC, Wen SC: Comparison of cutting balloon versus high-pressure balloon angioplasty for resistant venous stenoses of native hemodialysis fistulas. J Vasc Interv Radiol 19: 877–883, 2008